STARR CHRISTOPHER M
Director
Sale 10b5-1
- Shares
- 799
- Price
- $79.67
- Value
- $63,656
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•39 filings
MNPR
Monopar Therapeutics
Net sales of $4.8M over the last 3 months
5 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 1 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$4,830,506
0 buyers · 5 sellers
12-month purchases
$104,925
1 distinct insiders
12-month sales
$5,174,395
6 distinct insiders
Highlighted alerts
4
26 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
1 executive purchases found
Get MNPR insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
MNPR overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
30
Voluntary view
P/S trades after deterministic checks
67
Administrative noise
Stored, never alerted
42
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- F
- Shares
- 597
- Price
- $92.59
- Footnotes
- 2
Represents additional shares withheld by the issuer to pay for the applicable withholding tax due to administrative error in connection with the vesting and settlement of 12,873 restricted stock units on June 30, 2026, as reported on a Form 4 filed July 2, 2026. Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
STARR CHRISTOPHER M
Director
Sale 10b5-1
- Shares
- 2,970
- Price
- $78.82
- Value
- $234,095
STARR CHRISTOPHER M
Director
Sale 10b5-1
- Shares
- 4,631
- Price
- $78.09
- Value
- $361,635
Robinson Chandler
Chief Executive Officer
Sale 10b5-1
- Shares
- 600
- Price
- $89.79
- Value
- $53,874
Robinson Chandler
Chief Executive Officer
Sale 10b5-1
- Shares
- 8,368
- Price
- $88.97
- Value
- $744,501
Robinson Chandler
Chief Executive Officer
Sale 10b5-1
- Shares
- 9,638
- Price
- $87.96
- Value
- $847,758
Robinson Chandler
Chief Executive Officer
Sale 10b5-1
- Shares
- 10,450
- Price
- $87.15
- Value
- $910,718
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 590
- Price
- $113.84
- Value
- $67,166
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 602
- Price
- $112.93
- Value
- $67,984
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 1,098
- Price
- $111.84
- Value
- $122,800
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 700
- Price
- $110.65
- Value
- $77,455
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 615
- Price
- $109.56
- Value
- $67,379
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 485
- Price
- $108.83
- Value
- $52,783
RIOUX PATRICE
Acting Chief Medical Officer
Sale 10b5-1
- Shares
- 1
- Price
- $111.26
- Value
- $111.26
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 590
- Price
- $113.84
- Value
- $67,166
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 602
- Price
- $112.93
- Value
- $67,984
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 1,098
- Price
- $111.84
- Value
- $122,800
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 700
- Price
- $110.65
- Value
- $77,455
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 615
- Price
- $109.56
- Value
- $67,379
Tsuchimoto Kim R
Director
Sale 10b5-1
- Shares
- 485
- Price
- $108.83
- Value
- $52,783
Anderson Raymond
Director
Sale 10b5-1
- Shares
- 1,802
- Price
- $113.05
- Value
- $203,716
Anderson Raymond
Director
Sale 10b5-1
- Shares
- 646
- Price
- $111.07
- Value
- $71,751
Anderson Raymond
Director
Sale 10b5-1
- Shares
- 694
- Price
- $110.04
- Value
- $76,368
Anderson Raymond
Director
Sale 10b5-1
- Shares
- 1,802
- Price
- $113.05
- Value
- $203,716
Anderson Raymond
Director
Sale 10b5-1
- Shares
- 646
- Price
- $110.07
- Value
- $71,105
Anderson Raymond
Director
Sale 10b5-1
- Shares
- 694
- Price
- $110.04
- Value
- $76,368
Vu Quan Anh
Chief Financial Officer
PurchaseAlert
- Shares
- 1,500
- Price
- $69.95
- Value
- $104,925
KLAUSNER ARTHUR J
Director
SaleAlert
- Shares
- 461
- Price
- $68.09
- Value
- $31,389
KLAUSNER ARTHUR J
Director
SaleAlert
- Shares
- 4,660
- Price
- $67.06
- Value
- $312,500
Tactic Pharma LLC
10% owner
SaleAlert
- Shares
- 550,229
- Price
- $63.61
- Value
- $34,999,957
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 01, 2026 | STARR CHRISTOPHER M Director | Sale | 799 | $79.67 | $63,656 | |
| Oct 01, 2026 | STARR CHRISTOPHER M Director | Sale | 2,970 | $78.82 | $234,095 | |
| Oct 01, 2026 | STARR CHRISTOPHER M Director | Sale | 4,631 | $78.09 | $361,635 | |
| Sep 24, 2026 | Robinson Chandler Chief Executive Officer | Sale | 600 | $89.79 | $53,874 | |
| Sep 24, 2026 | Robinson Chandler Chief Executive Officer | Sale | 8,368 | $88.97 | $744,501 | |
| Sep 24, 2026 | Robinson Chandler Chief Executive Officer | Sale | 9,638 | $87.96 | $847,758 | |
| Sep 24, 2026 | Robinson Chandler Chief Executive Officer | Sale | 10,450 | $87.15 | $910,718 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 590 | $113.84 | $67,166 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 602 | $112.93 | $67,984 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 1,098 | $111.84 | $122,800 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 700 | $110.65 | $77,455 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 615 | $109.56 | $67,379 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 485 | $108.83 | $52,783 | |
| Aug 26, 2026 | RIOUX PATRICE Acting Chief Medical Officer | Sale | 1 | $111.26 | $111.26 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 590 | $113.84 | $67,166 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 602 | $112.93 | $67,984 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 1,098 | $111.84 | $122,800 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 700 | $110.65 | $77,455 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 615 | $109.56 | $67,379 | |
| Aug 26, 2026 | Tsuchimoto Kim R Director | Sale | 485 | $108.83 | $52,783 | |
| Aug 25, 2026 | Anderson Raymond Director | Sale | 1,802 | $113.05 | $203,716 | |
| Aug 25, 2026 | Anderson Raymond Director | Sale | 646 | $111.07 | $71,751 | |
| Aug 25, 2026 | Anderson Raymond Director | Sale | 694 | $110.04 | $76,368 | |
| Aug 25, 2026 | Anderson Raymond Director | Sale | 1,802 | $113.05 | $203,716 | |
| Aug 25, 2026 | Anderson Raymond Director | Sale | 646 | $110.07 | $71,105 | |
| Aug 25, 2026 | Anderson Raymond Director | Sale | 694 | $110.04 | $76,368 | |
| Dec 26, 2025 | Vu Quan Anh Chief Financial Officer | Purchase | 1,500 | $69.95 | $104,925 | |
| Dec 18, 2025 | KLAUSNER ARTHUR J Director | Sale | 461 | $68.09 | $31,389 | |
| Dec 18, 2025 | KLAUSNER ARTHUR J Director | Sale | 4,660 | $67.06 | $312,500 | |
| Sep 24, 2025 | Tactic Pharma LLC 10% owner | Sale | 550,229 | $63.61 | $34,999,957 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.